Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Tumor Tissue Available”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Not applicableLooking for participantsNCT04677205
What this trial is testing

Molecular Signature From Tumor to Lymph Nodes

Who this might be right for
Lung CancerStage IIIA-cN2Operated With Curative Intent+2 more
Assistance Publique - Hôpitaux de Paris 200
Very early researchStudy completedNCT01132014
What this trial is testing

Autologous OC-DC Vaccine in Ovarian Cancer

Who this might be right for
ChemotherapyTumorOvarian Cancer
Abramson Cancer Center at Penn Medicine 67
Post-approval studies (Phase 4)Looking for participantsNCT06676384
What this trial is testing

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

Who this might be right for
IgA NephropathyRenal Insufficiency, ChronicIgA Vasculitis+1 more
Christian Medical College, Vellore, India 585